Table 1 Relationship between Cx32 expression and clinicopathologic variables in 96 HCC tissues
Clinicopathologic parameters | n | Cx32 expression | χ 2 | P | r | |
|---|---|---|---|---|---|---|
Low | High | |||||
All cases | 96 | 48 | 48 | Â | Â | Â |
Age (years) | ||||||
  ≤ 50 | 40 | 19 (39.6%) | 21 (43.8%) |  |  |  |
 >50 | 56 | 29 (60.4%) | 27 (56.3%) | 0.171 | 0.679 | – |
Sex | ||||||
 male | 83 | 41 (85.4%) | 42 (87.5%) |  |  |  |
 female | 13 | 7 (14.6%) | 6 (12.5%) | 0.089 | 0.765 | – |
Serum AFP (ng/ml) | ||||||
  ≤ 25 | 36 | 17 (35.4%) | 19 (39.6%) |  |  |  |
 >25 | 60 | 31 (64.6%) | 29 (60.4%) | 0.178 | 0.673 | – |
Tumor size (cm) | ||||||
  ≤ 5 | 26 | 14 (22.9%) | 12 (25%) |  |  |  |
 >5 | 70 | 34 (70.8%) | 36 (75%) | 0.211 | 0.646 | – |
HBsAg | ||||||
 Negative | 15 | 9 (19.6%) | 6 (12%) |  |  |  |
 Positive | 81 | 37 (80.4%) | 44 (88%) | 1.040 | 0.308 | – |
Vascular invasion | ||||||
 absent | 89 | 45 (93.8%) | 44 (91.7%) |  |  |  |
 present | 7 | 3 (6.3%) | 4 (8.3%) | 0.154 | 0.695 | – |
Differentiation | ||||||
 Well-moderate (1–2 grade) | 57 | 40 (80.3%) | 17 (35.4%) |  |  |  |
 Poor-differentiate (3–4 grade) | 39 | 8 (16.7%) | 3 (64.6%) | 22.854 | 0.000 | 0.488 |
TNM Stage | ||||||
 I + II | 33 | 25 (52.1%) | 8 (16.7%) |  |  |  |
 III | 63 | 23 (47.9%) | 40 (83.3%) | 13.345 | 0.000 | 0.373 |
Liver Cirrhosis | ||||||
 absent | 66 | 30 (62.5%) | 36 (75%) |  |  |  |
 present | 30 | 18 (37.5%) | 12 (25%) | 1.745 | 0.186 | – |